Diversify Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
Diversify Advisory Services's AZN Position: Q2 2026 in Review
Diversify Advisory Services increased its AstraZeneca (AZN) stake by 356% in Q2 2026, buying an estimated $1.76M and bringing the position to 12,005 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #405.
Diversify Advisory Services first reported a position in AZN in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.06M in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Diversify Advisory Services held 12,005 shares of AstraZeneca worth $2.04M as of Q2 2026.
- Diversify Advisory Services bought 9,371 AstraZeneca shares in Q2 2026, an estimated $1.76M.
- AstraZeneca made up 0.03% of Diversify Advisory Services's portfolio in Q2 2026, its #405 holding.
- Diversify Advisory Services first reported a position in AstraZeneca in Q1 2024 and has held it in 10 quarters since.
- Diversify Advisory Services's AstraZeneca position peaked at $2.06M in Q4 2025.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Diversify Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.